Pressure BioSciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1996
Net Income	-6,403.12	-29.31	-16.82	-34.6	-24.35	-11.66	Upgrade
Depreciation & Amortization	0.11	0.11	0.12	0.11	0.13	0.12	Upgrade
Share-Based Compensation	1.71	2,636	0.22	0.25	0.49	1.12	Upgrade
Other Operating Activities	6,398	-2,610.43	12.01	29.37	18.85	4.09	Upgrade
Operating Cash Flow	-3.19	-3.19	-4.48	-4.87	-4.88	-6.33	Upgrade
Capital Expenditures	-0.01	-0.01	-0.02	-0.12	-0	-0.02	Upgrade
Other Investing Activities	-	-	-	-	-0.8	-	Upgrade
Investing Cash Flow	-0.01	-0.01	-0.02	-0.12	-0.8	-0.02	Upgrade
Common Stock Issued	0.15	0.23	0.03	7,266	255.26	3,275	Upgrade
Share Repurchases	0	0	0	-7,081.68	44.45	-3,070	Upgrade
Other Financing Activities	3.12	3.04	4.35	-14,342.53	-205.14	-6,338.82	Upgrade
Financing Cash Flow	3.27	3.27	4.37	5.11	5.67	6.28	Upgrade
Net Cash Flow	0.08	0.08	-0.13	0.11	-0.01	-0.07	Upgrade
Free Cash Flow	-3.19	-3.19	-4.5	-4.99	-4.88	-6.35	Upgrade
Free Cash Flow Margin	-161.47%	-161.47%	-260.14%	-249.28%	-400.20%	-350.88%	Upgrade
Free Cash Flow Per Share	-0.10	-0.14	-0.41	-0.75	-1.48	-3.20	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.